Isoray, Inc. – AMEX:ISR
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
Isoray stock price monthly change
+37.05%
month
Isoray stock price quarterly change
+2.40%
quarter
Isoray stock price yearly change
+4.26%
year
Isoray key metrics
Market Cap | N/A |
Enterprise value | 33.97M |
P/E | -5.25 |
EV/Sales | 3.78 |
EV/EBITDA | -3.54 |
Price/Sales | 6.08 |
Price/Book | 0.99 |
PEG ratio | 0.07 |
EPS | -92.26 |
Revenue | N/A |
EBITDA | -27.29M |
Income | -46.50M |
Revenue Q/Q | -445.28% |
Revenue Y/Y | -100% |
Profit margin | -115.91% |
Oper. margin | -121.48% |
Gross margin | 35.51% |
EBIT margin | -121.48% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIsoray stock price history
Isoray stock forecast
Isoray financial statements
| Mar 2023 | 2.06M | -371K | -17.98% |
|---|---|---|---|
| Jun 2023 | 2.08M | -11.10M | -531.9% |
| Sep 2023 | 2.18M | -10.35M | -473.96% |
| Dec 2023 | -6.33M | -24.67M | 389.44% |
| 2022-09-28 | -0.01 | -0.01 |
|---|---|---|
| 2022-11-14 | -0.03 | -0.03 |
| 2023-02-16 | -0.04 | -0.02 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2017 | |
|---|---|
| 2019 | 0.04% |
| 2020 | 0.03% |
| 2022 | |
| 2023 |
| Mar 2023 | 127645000 | 9.61M | 7.53% |
|---|---|---|---|
| Jun 2023 | 120145000 | 11.49M | 9.57% |
| Sep 2023 | 110518000 | 11.74M | 10.63% |
| Dec 2023 | 97891000 | 22.71M | 23.2% |
| Mar 2023 | -9.72M | 25.26M | -80K |
|---|---|---|---|
| Jun 2023 | 255K | 0 | 0 |
| Sep 2023 | 259K | 0 | 0 |
| Dec 2023 | -27.70M | -889K | 865K |
Isoray alternative data
| Aug 2023 | 66 |
|---|---|
| Sep 2023 | 66 |
| Oct 2023 | 66 |
| Nov 2023 | 66 |
| Dec 2023 | 66 |
| Jan 2024 | 66 |
| Feb 2024 | 66 |
| Mar 2024 | 66 |
| Apr 2024 | 66 |
| May 2024 | 66 |
| Jun 2024 | 66 |
| Jul 2024 | 66 |
Isoray other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 932968 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2023 10 Nov 2022 | Q1 2023 Earnings Call Transcript |
| Q4 2022 28 Sep 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 10 May 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 8 Feb 2022 | Q2 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Ms. Lori A. Holmes-Woods (1962) Chief Executive Officer & Director | $371,190 |
| Ms. Jennifer Streeter (1970) Chief Operating Officer & Vice President of HR | $266,350 |
| Mr. William A. Cavanagh III (1966) Chief R&D Officer | $253,340 |
-
When is Isoray's next earnings date?
Unfortunately, Isoray's (ISR) next earnings date is currently unknown.
-
Does Isoray pay dividends?
No, Isoray does not pay dividends.
-
What is Isoray's stock symbol?
Isoray, Inc. is traded on the AMEX under the ticker symbol "ISR".
-
What is Isoray's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Isoray?
Shares of Isoray can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Isoray's key executives?
Isoray's management team includes the following people:
- Ms. Lori A. Holmes-Woods Chief Executive Officer & Director(age: 63, pay: $371,190)
- Ms. Jennifer Streeter Chief Operating Officer & Vice President of HR(age: 55, pay: $266,350)
- Mr. William A. Cavanagh III Chief R&D Officer(age: 59, pay: $253,340)
-
How many employees does Isoray have?
As Jul 2024, Isoray employs 66 workers.
-
When Isoray went public?
Isoray, Inc. is publicly traded company for more then 23 years since IPO on 31 May 2002.
-
What is Isoray's official website?
The official website for Isoray is isoray.com.
-
Where are Isoray's headquarters?
Isoray is headquartered at 350 Hills Street, Richland, WA.
-
How can i contact Isoray?
Isoray's mailing address is 350 Hills Street, Richland, WA and company can be reached via phone at +509 3751202.
Isoray company profile:
Isoray, Inc.
isoray.comExchange:
AMEX
Full time employees:
66
Industry:
Medical - Devices
Sector:
Healthcare
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
350 Hills Street
Richland, WA 99354
Richland, WA 99354
CIK: 0000728387
ISIN: US46489V1044
CUSIP: 46489V104
